Results 161 to 170 of about 2,812,482 (299)

Revisiting Mission‐Oriented Cancer Research to tackle the increasing burden of cancer in Europe–a policy perspective

Molecular Oncology, EarlyView.
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor, Julio Celis, Ulrik Ringborg   +2 more
wiley   +1 more source

Assessing the Economic Implications of a Diagnosis-Related Groups Payment System in Iran's Health System Transformation Plan. [PDF]

Int J Prev Med
Khadivi Y, Nabi Meibodi M, Saghafi F, Khadivi R.   +3 more
europepmc   +1 more source

The DEMATEL method explores the interdependent relationship structure and weights for diagnosis-related groups system. [PDF]

Front Public Health, 2022
Zou T, Jin Y, Chuang YC, Chien CW, Tung TH.   +4 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Cost shifting or cost cutting by hospitals as a response to reimbursement reform? The case of diagnosis-related groups (DRG) scheme in China. [PDF]

Front Public Health
Wang J, Zhu J, Hu K, Chen Y, Zhang J, Wu X.   +5 more
europepmc   +1 more source

Physician perspectives on the implications of the diagnosis-related groups for medical practice in Turkey: A qualitative study. [PDF]

Int J Health Plann Manage, 2022
Aktas P.
europepmc   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Improving the clinical ability and quality of endocrinology department with diagnosis-related groups tool. [PDF]

Ann Transl Med, 2022
Ding S, Jiang X, Zheng Y, Feng T, Mao H, Chen Z, Cai W, Wang Z.   +7 more
europepmc   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source

Unpacking the cost implications of diagnosis-related groups reform for lumbar disc herniation patients in Chinese medicine: a closer look at evidence from China. [PDF]

Front Public Health
Chen ME, Wang YH, Yu J, Xia SJ, Zhang XX, Wang Y, Yuan YS, Jia X, Sun HN, Wu GP, Wang JY, Cong TZ, Kong FX, Hou HJ, Yang JY, Wang ZW.   +15 more
europepmc   +1 more source